Prof. Cafer Sadık ZORKUN

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

2513

H-Index (WoS)

Citation (Scopus)

928

H-Index (Scopus)

Citation (Sum Other)

2173

Thesis Advisory

Open Access

UN Sustainable Development Goals

Biography

I am a clinical cardiologist focused on "delivering effective and high quality cardiology based care to patients who are being treated or have previously been treated for cancer".

Education

2007 - 2009

Post Doctorate

Harvard University, Harvard Medical School, Tımı Study Group, United States Of America

2008 - 2008

Expertise In Medicine

Istanbul University, Istanbul Medical Faculty, Kardiyoloji Anabilim Dali, Turkey

2001 - 2007

Expertise In Medicine

Krakow Jagiellonski Üniversitesi, The John Paul Iı Hospital, Department Of Hemodynamics And Angiocardiography, Poland

2001 - 2006

Doctorate

Krakow Jagiellonski Üniversitesi, Collegium Medicum, Cardiology, Poland

1982 - 1989

Undergraduate

Istanbul University, Istanbul Medical Faculty, Tip Doktoru, Turkey

Dissertations

2008

Expertise In Medicine

Primer koroner anjiyoplasti teknikleri ve ilaç tedavisinin sol ventrikül fonksiyonları ve miyokard perfüzyonu üzerindeki etkileri.

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

Research Areas

Medicine

Internal Medicine Sciences

Cardiovascular

Health Sciences

Academic Positions

2024 - Present

Professor

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

2019 - 2024

Associate Professor

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

2016 - 2019

Associate Professor

Trakya University, Faculty of Medicine, Depertment of Internal Medicine

Courses

Associate Degree

CardioOncology II

Cardiovascular Genetics

Clinical Electrocardiography IV

Clinical Electrocardiography III

Echocardiography

Bradyarrhythmias: Diagnosis and Treatment I

Bradyarrhythmias: Diagnosis and Treatment II

Mitral Insufficiency

Diseases of the Pericardium

Cardiovascular Pharmacology II

Cardiovascular Pharmacology I

CardioOncology I

Cardiac Emergencies II

Pathophysiology of Myocardial Ischemia

Mitral Stenosis

Infective Endocarditis and other Endocardial Diseases

Cardiomyopathies and other Myocardial Diseases

Chronic Cor Pulmonale

Cardiac Emergencies I

Acute Left Heart Failure, Pulmonary Edema and Cardiogenic Shock

Supervised Theses

2020

Expertise In Medicine

Normal sınırlardaki 'yüksek duyarlıklı troponin T'değişkenliğinin efor testi pozitifliği ve koroner anatomisi üzerine olan etkisinin araştırılması

Zorkun C. S. (Advisor)

M.YILMAZ(Student)

Articles

2025

1. An Ignored Population in Emergency Department: Cardio-Oncology Patients

Salt Ö., ZORKUN C. S., Aytürk Salt S.

Life , vol.15, no.4, 2025 (SCI-Expanded)

2025

2. Symptomatic Severe Bradycardia during Pazopanib Treatment Pazopanib Tedavisi Sırasında Semptomatik Şiddetli Bradikardi

ZORKUN C. S., Eren Ö. A.

Turk Kardiyoloji Dernegi Arsivi , vol.53, no.2, pp.140-142, 2025 (ESCI)

2024

3. BLEOMYCIN-INDUCED PULMONARY HYPERTENSION: AN UNDERRATED PHENOMENON WITH IMPORTANT IMPLICATIONS IN THE SETTING OF HIGH-RISK CLINICAL SCENARIOS

Yalta K., ZORKUN C. S., Yetkın E.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , vol.41, no.2, 2024 (SCI-Expanded)

2023

4. The Correlation between Elevated HDL-Cholesterol, Body Mass Index, and Presence of Thyroid Nodules: A Retrospective Analysis

Zorkun C. S., Yalta K., Eren A., Yetkin E.

Journal of Clinical Medicine , vol.12, no.23, 2023 (SCI-Expanded)

2023

5. Can high-sensitive troponin levels within the normal range predict positivity in treadmill test?

Yilmaz M., Atici A., Sonsöz M. R., Çevik E., Orta H., Demirtakan Z. G., et al.

Coronary Artery Disease , vol.34, no.3, pp.202-209, 2023 (SCI-Expanded)

2022

6. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

Lyon A. R., Lopez-Fernandez T., Couch L. S., Asteggiano R., Aznar M. C., Bergler-Klein J., et al.

EUROPEAN HEART JOURNAL , vol.43, no.41, pp.4229-4361, 2022 (SCI-Expanded)

2022

7. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Lyon A. R., López-Fernández T., Lancellotti P., Thuny F., Abdelhamid M., Aboyans V., et al.

European Heart Journal Cardiovascular Imaging , vol.23, no.10, 2022 (SCI-Expanded)

2021

8. Blood pressure, autonomic stress, and inflammatory markers during sleep deprivation and recovery in healthy men

Bozer O., KAYA O., Ozturk G., BULUT E., Zorkun C. S., ÖZTÜRK L.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.6, pp.407-413, 2021 (SCI-Expanded)

2020

9. Relationship between the infarct localization and left ventricular rotation parameters following acute ST-segment elevation myocardial infarction

Demirkiran A., ZORKUN C. S., Demir H. D., TOPÇU B., Emre E., Ozdemir N.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.48, no.3, pp.255-262, 2020 (ESCI)

2020

10. Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications

Yalta K., YILMAZ M. B., Yalta T., PALABIYIK O., TAYLAN G., ZORKUN C. S.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS , vol.25, no.1, pp.15-26, 2020 (SCI-Expanded)

2019

11. How Old is Too Old? Observing A Centenarian After Primary PCI

KAYA Ç., ZORKUN C. S., YALTA A. K.

E Journal of Cardiovascular Medicine , vol.7, no.2, pp.101-103, 2019 (Peer-Reviewed Journal)

2019

12. Natriuretic Peptides in Clinical Practice

ÇAVUŞOĞLU Y., Alper A. T., Altay H., ÇELİK A., Demirkan B., Guvenc T. S., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , pp.1-40, 2019 (SCI-Expanded)

2018

13. Late coronary ischemic syndromes associated with transcatheter aortic valve implantation: A review of mechanistic and clinical aspects

Yalta K., Zorkun C. S., Yilmaztepe M., Gurlertop Y.

INDIAN HEART JOURNAL , vol.70, no.6, pp.901-906, 2018 (ESCI)

2018

14. Strain can hide some states Reply

Demirkiran A., Albayrak N., ALBAYRAK Y., ZORKUN C. S.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.20, no.4, pp.252, 2018 (SCI-Expanded)

2018

15. Author`s Reply

Demirkıran A., Albayrak N., Albayrak Y., ZORKUN C. S.

Anatolian journal of cardiology , vol.20, no.4, pp.252, 2018 (SCI-Expanded)

2018

16. Mechanically expanding transcatheter aortic valves: pros and cons of a unique device technology

Yalta K., GÜRDOĞAN M., Zorkun C. S., Gurlertop Y.

CARDIOVASCULAR DIAGNOSIS AND THERAPY , vol.8, no.4, pp.538-542, 2018 (SCI-Expanded)

2018

17. Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive?

Yalta K., Ucar F., Yilmaztepe M., Zorkun C. S.

INDIAN HEART JOURNAL , vol.70, no.2, pp.326-327, 2018 (ESCI)

2018

18. Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure

Yalta K., Zorkun C. S.

INDIAN HEART JOURNAL , vol.70, no.1, pp.196, 2018 (ESCI)

2017

19. Pentraxin-3 and its further clinical implications in women with preeclampsia

Yalta K., Ucar F., Yilmaztepe M., Zorkun C. S.

INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.246, pp.61, 2017 (SCI-Expanded)

2016

20. Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study)

Tokgozoglu L., ÖZDEMİR R., Altindag R., CEYHAN C., Yeter E., Ozturk C., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , no.1, pp.53-64, 2016 (ESCI)

2014

21. Elevated mean pulmonary artery pressure in patients with mild-to-moderate mitral stenosis: a useful predictor of worsening renal functions? Reply

ZORKUN C. S., Amioglu G., Bektasoglu G., ZORLU A., Ekinozu I., TURGUT O. O., et al.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.14, no.3, pp.306-307, 2014 (SCI-Expanded)

2014

22. Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)

Kunadian V., Giugliano R. P., Newby L. K., Zorkun C. S., Guo J., Bagai A., et al.

AMERICAN JOURNAL OF CARDIOLOGY , vol.113, no.8, pp.1297-1305, 2014 (SCI-Expanded)

2014

23. Coronary Slow Flow Phenomenon Associated with High Serum Levels of Soluble CD40 Ligand and Urotensin II: A Multi-Marker Approach

Demir B., Caglar I. M., Tureli H. O., Pirhan O., Aciksari G., Cifci S., et al.

CLINICAL LABORATORY , no.11, pp.1909-1920, 2014 (SCI-Expanded)

2014

24. Re: Elevated mean pulmonary artery pressure in patients with mild-to-moderate mitral stenosis: A useful predictor of worsening renal functions?

ZORKUN C. S., Amioǧlu G., Bektaşoǧlu G., Zorlu A., Ekinözü I., TURGUT O. O., et al.

Anadolu Kardiyoloji Dergisi , vol.14, no.3, pp.306-307, 2014 (SCI-Expanded)

2013

25. Coronary collateral development might be impaired by decreases in glomerular filtration rate Reply

ZORKUN C. S., Akkaya E., ZORLU A., TANDOĞAN İ.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , vol.13, no.5, pp.503, 2013 (SCI-Expanded)

2013

26. RE: Coronary collateral development might be impaired by decreases in glomerular filtration rate RE: Koroner kollateral gelişimi glomerular filtrasyon hizindaki azalmalardan etkilenebilir

ZORKUN C. S., Akkaya E., Zorlu A., Tandoǧan I.

Anadolu Kardiyoloji Dergisi , vol.13, no.5, pp.503, 2013 (SCI-Expanded)

2013

27. Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

Kunadian V., James S. K., Wojdyla D. M., Zorkun C. S., Wu J., Storey R. F., et al.

JACC-CARDIOVASCULAR INTERVENTIONS , vol.6, no.7, pp.671-683, 2013 (SCI-Expanded)

2013

28. Determinants of coronary collateral circulation in patients with coronary artery disease

Zorkun C. S., Akkaya E., ZORLU A., TANDOĞAN İ.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.13, no.2, pp.146-151, 2013 (SCI-Expanded)

2013

29. Elevated mean pulmonary artery pressure in patients with mild-to-moderate mitral stenosis: a useful predictor of worsening renal functions?

Zorkun C. S., Amioglu G., Bektasoglu G., ZORLU A., Ekinozu I., TURGUT O. O., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.13, no.5, pp.457-464, 2013 (SCI-Expanded)

2012

30. Newer Pharmaceutical Agents for STEMI Interventions

Chakrabarti A. K., Patel S. J., Salazar R. L., Gopalakrishnan L., Kumar V., Rastogi U., et al.

Interventional Cardiology Clinics , vol.1, no.4, pp.429-440, 2012 (Scopus)

2012

31. Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention An EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) Angiographic Substudy

Pride Y. B., Mohanavelu S., Zorkun C. S., Kunadian V., Giugliano R. P., Newby L. K., et al.

JACC-CARDIOVASCULAR INTERVENTIONS , vol.5, no.9, pp.927-935, 2012 (SCI-Expanded)

2010

32. Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression A TRITON TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel Thrombolysis In Myocardial Infarction 38) Substudy

Pride Y. B., Tung P., Mohanavelu S., Zorkun C. S., Wiviott S. D., Antman E. M., et al.

JACC-CARDIOVASCULAR INTERVENTIONS , vol.3, no.8, pp.806-811, 2010 (SCI-Expanded)

2009

33. Letter to the Editor

ZORKUN C. S., Cagli K. E., Aras D.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.23, no.4, pp.458-285, 2009 (ESCI)

2009

34. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy

Pride Y. B., Wiviott S. D., Buros J. L., Zorkun C. S., Tariq M. U., Antman E. M., et al.

AMERICAN HEART JOURNAL , vol.158, no.3, 2009 (SCI-Expanded)

2009

35. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years

Kunadian V., Harrigan C., Zorkun C. S., Palmer A. M., Ogando K. J., Biller L. H., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.27, no.3, pp.316-328, 2009 (SCI-Expanded)

2009

36. Transfusion associated microchimerism: a heretofore little recognized complication following transfusion

Kunadian V., Zorkun C. S., Gibson W. J., Nethala N., Harrigan C., Palmer A. M., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.27, no.1, pp.57-67, 2009 (SCI-Expanded)

2009

37. Akut miyokard infarktüsü nedeniyle primer perkütan girişim uygulanan hastalarda başvuru anindaki hs-CRP düzeyinin önemi

ZORKUN C. S.

Turk Kardiyoloji Dernegi Arsivi , vol.37, no.4, pp.285, 2009 (Scopus)

2009

38. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis

Gibson C. M., Pride Y. B., Aylward P. E., Col J. J., Goodman S. G., Gulba D., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.27, no.1, pp.11-17, 2009 (SCI-Expanded)

2008

39. Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction

Kunadian V., Zorkun C. S., Williams S. P., Biller L. H., Palmer A. M., Ogando K. J., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.26, no.3, pp.234-242, 2008 (SCI-Expanded)

2008

40. Intracoronary administration of abciximab in ST-elevation myocardial infarction

Gibson C. M., Zorkun C. S., Kunadian V.

CIRCULATION , no.1, pp.6-8, 2008 (SCI-Expanded)

2006

41. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

Gibson C. M., Zorkun C. S., Molhoek P., Zmudka K., Greenberg M., Mueller H., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.22, no.1, pp.13-21, 2006 (SCI-Expanded)

2004

42. Right ventricular infarction: novel modalities of treatment Zawał mieśnia prawej komory serca: nowe sposoby leczenia.

Zmudka K., Tomala M., Krochin M., Siniawski H., Godlewski J., Guzik B., et al.

Przegla̧d lekarski , vol.61, no.6, pp.705-711, 2004 (Scopus)

2004

43. Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes Pierwotna angioplastyka wieńcowa w świeżym zawale serca u chorych z cukrzyca̧

Dudek D., Mielecki W., Wizimirski M., Rakowski T., Dziewierz A., Sorysz D., et al.

Kardiologia Polska , vol.61, no.9, pp.232-242, 2004 (Scopus)

2004

44. Incidence of ischemic mitral regurgitation in 1155 consecutive acute myocardial infarction patients treated with primary or facilitated angioplasty.

Zmudka K., Zorkun C. S., Musialek P., Podolec P., Sadowski J., Piwowarska W., et al.

ACTA CARDIOLOGICA , vol.59, no.2, pp.243-244, 2004 (SCI-Expanded)

2004

45. The degree of restored myocardial perfusion in acute myocardial infarction influences immediate and long-term results of primary coronary angioplasty Stopień perfuzji miokardium przywrócony metoda̧ pierwotnej angioplastyki w zawale serca wpływa na bezpośredni i odległy wynik kliniczny

Zmudka K., Zalewski J., Przewłocki T., Zajdel W., Czunko P., Durak M., et al.

Kardiologia Polska , vol.61, no.10, pp.316-328, 2004 (Scopus)

2003

46. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals

Dudek D., Zmudka K., Kaluza G., Kuta M., Pieniazek P., Przewlocki T., et al.

AMERICAN JOURNAL OF CARDIOLOGY , vol.91, no.2, pp.227-230, 2003 (SCI-Expanded)

2002

47. Assessment of myocardial reperfusion in patients with acute myocardial infarction treated with combination of fibrinolysis and IIb/IIIa platelet inhibitor Angiograficzna ocena reperfuzji miokardium u chorych ze świezym zawałem serca leczonych kombinacja leków fibrynolitycznych oraz blokerów płytkowego receptora IIb/IIIa.

Dudek D., Bartuś S., Zmudka K., Kuta M., Legutko J., Wizimirski M., et al.

Przegla̧d lekarski , vol.59, no.1, pp.1-6, 2002 (Scopus)

2002

48. Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have?

ZORKUN C. S., Zmudka K., Dudek D., Przewłocki T., Trebacz J., Musiałek P., et al.

Przegla̧d lekarski , vol.59, no.11, pp.932-940, 2002 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences

2025

1. Kardiyak Amiloidoz Tanısında Kantitatif ve Semikantitatif Değerlendirme: Hangisi Daha Güvenilir?

İnal E., Zorkun C. S., Arça B., Işık E. G., Kuyumcu S., Şanlı Y.

37. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 9 - 13 April 2025, pp.190, (Summary Text)

2024

2. An Atypical Prostate Cancer (Case Presentation)

Zorkun C. S., Dizdar M. Y., İribaş Çelik A., Denizli M.

20th International Congress of Update in Cardiology and Cardiovascular Surgery Sözlü Sunum, İstanbul, Turkey, 6 - 09 June 2024, (Unpublished)

2015

3. ROLE OF MEDIA ON DISCONTINUATION OF STATIN THERAPY

Tokgoezoglu L., Ozdemir R., Altindag R., Ceyhan C., Yeter E., Ozturk C., et al.

83rd Congress of the European-Atherosclerosis-Society (EAS), Glasgow, England, 22 - 25 March 2015

2011

4. ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL

Kunadian V., ZORKUN C. S., James S., Wu J., Muhammad A., Storey R., et al.

60th Annual Scientific Session and Expo of the American-College-of-Cardiology, Louisiana, United States Of America, 3 - 05 April 2011, vol.57, (Summary Text)

2008

5. Larger Saphenous Vein Grafts in Relation to Native Artery are Associated with Reduced TIMI Grade 3 Flow but Improved Myocardial Perfusion at 1 Year: A PREVENT IV Analysis

Ciaglo L. N., Karmpaliotis D., Kunadian V., Gibson W. J., Buros J. L., ZORKUN C. S., et al.

81st Annual Scientific Session of the American-Heart-Association, Louisiana, United States Of America, 8 - 12 November 2008, vol.118, (Summary Text)

2006

6. Invasive therapeutic strategies in acute myocardial infarction

ZORKUN C. S., Zmudka K., Pasowicz M.

18th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, Kiribati, 22 - 27 October 2006, vol.98

2006

7. Myocardial reperfusion in STEMI; A high-volume single-center observation.

ZORKUN C. S., Zmudka K., Pasowicz M., Tracz W.

11th Annual Symposium of the Interventional Vascular Therapeutics Angioplasty Summit-Transcatheter Cardiovascular Therapeutics Asia Pacific Symposium, Seoul, South Korea, 26 - 28 April 2006, vol.97

2006

8. Ischemic mitral regurgitation in patients after successful percutaneous coronary intervention in ST-segment elevation myocardial infarction.

ZORKUN C. S., Zmudka K., Pasowicz M., Tracz W.

11th Annual Symposium of the Interventional Vascular Therapeutics Angioplasty Summit-Transcatheter Cardiovascular Therapeutics Asia Pacific Symposium, Seoul, South Korea, 26 - 28 April 2006, vol.97, (Summary Text)

2004

9. Predictive value of NT-pro brain natriuretic peptide in left ventricular injury, function recovery and remodeling after acute myocardial infarction treated with facilitated coronary angioplasty

Zalewski J., El-Massri N., Durak M., ZORKUN C. S., Zajdel W., Dudek D., et al.

ESC Congress 2004, Munich, Germany, 28 August - 01 September 2004, vol.25, pp.408, (Summary Text)

2004

10. Effect of adjunctive glucose insulin potassium infusion in patients with mild to moderate heart failure in the setting of acute myocardial infarction

ZORKUN C. S., Zmudka K., Pasowicz M.

ESC Congress 2004, Munich, Germany, 28 August - 01 September 2004, vol.25, pp.409-410, (Summary Text)

2004

11. Tumor necrosis factor-alpha measurement at baseline inversely correlates with coronary collaterals and predicts left ventricular function in patients with st elevation myocardial infarction

ZORKUN C. S., Pieniazek R., Zmudka K., Pasowicz M.

ESC Congress 2004, Munich, Germany, 28 August - 01 September 2004, vol.25, pp.412, (Summary Text)

2004

12. Evolution of thrombolysis in myocardial infarction myocardial perfusion grade during primary coronary angioplasty in acute myocardial infarction predicts long-term recovery of left ventricular function

Zalewski J., Zmudka K., Musialek P., ZORKUN C. S., Kadzielski A., Zajdel W.

54th Annual Scientific Session of the American-College-of-Cardiology, Louisiana, United States Of America, 7 - 10 March 2004, vol.43, (Summary Text)

2003

13. Inflammatory markers, ST segment resolution time and myocardial perfusion grade relations in patients with acute myocardial infarction

ZORKUN C. S., Pieniazek P., Zmudka K., Zalewski J., Legutko J., Dudek D., et al.

76th Annual Scientific Session of the American-Heart-Association, ORLANDO, FLORIDA, 7 - 12 November 2003, vol.108, pp.383

2003

14. Myocardial signal intensity analysis with magnetic resonance imaging (T2-weighted short time inversion recovery sequence-STIR) in patients with suspected or known myocarditis - a preliminary report

Klimeczek P., Pasowicz M., ZORKUN C. S., Zmudka K., Piwowarska W., Tracz W.

Congress of the European-Society-of-Cardiology, Vienna, Austria, 30 August - 03 September 2003, vol.24, pp.249

2003

15. Prognostic value of ST segment resolution time and electrocardiogram measurement point relations in acute myocardial infarction: 6 months follow-up evaluations

Zmudka K., ZORKUN C. S., Sadowski J., Pasowicz M., Dziatkowiak A.

Congress of the European-Society-of-Cardiology, Vienna, Austria, 30 August - 03 September 2003, vol.24, pp.151, (Summary Text)

2003

16. Safety and efficacy of low versus very low dose of unfractioned heparin in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction

Dudek D., Dziewierz A., Legutko J., Bartus S., ZORKUN C. S., Rzeszutko L., et al.

Congress of the European-Society-of-Cardiology, Vienna, Austria, 30 August - 03 September 2003, vol.24, pp.191, (Summary Text)

2002

17. Facilitated percutaneous coronary interventions in patients with acute myocardial infarction transferred from remote hospitals

Dudek D., Zmudka K., Kuta M., Dziewierz A., ZORKUN C. S., Bartus S., et al.

Congress of the European-Society-of-Cardiology, Berlin, Germany, 31 August - 04 September 2002, vol.23, pp.342

Books

2023

1. Kardiyotoksik İlaç Kullanımına Sekonder Kalp Yetersizliği Yönetimi

ZORKUN C. S.

in: Kalp Yetersizliğine Fenotip Odaklı Yaklaşım, Yılmaz, Mehmet Birhan, Editor, Bilmedya, İstanbul, pp.107-112, 2023

2020

2. Kemoterapi ve radyoterapiye bağlı kardiyomiyopati

ZORKUN C. S.

in: Kalp Yetersizliğine Yol Açan Nadir Kardiyomiyopatiler: Tanı ve Tedavi Yaklaşımları, Çavuşoğlu, Yüksel, Editor, Türkiye Klinikleri, pp.30-39, 2020

2017

3. İnme sonrası kardiyak takip ve inmenin kardiyovasküler komplikasyonları

ZORKUN C. S.

in: Nörokardiyoloji, Cafer Sadık Zorkun, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.217-228, 2017

2017

4. Kardiyovasküler ilaçların nörolojik yan etkileri

ZORKUN C. S.

in: Nörokardiyoloji, , Editor, Nobel Tıp Kitabevleri, İstanbul, pp.285-290, 2017

2014

5. Kronik Akciğer Hastalarında Sağ Ventrikül Disfonksiyonu

ZORKUN C. S., ALTIN S.

in: SAĞ KALP YETERSİZLİĞİ, İBRAHİM KELEŞ, Editor, AKADEMİ YAYINEVİ, İstanbul, pp.156-169, 2014

2014

6. Kronik akciğer hastalarında sağ ventrikül disfonksiyonu

ZORKUN C. S., ALTIN S.

in: Sağ Kalp Yetersizliği, Keleş İbrahim, Editor, Akademi Yayınevi, İstanbul, pp.156-169, 2014

2001